Results 301 to 310 of about 2,453,090 (361)
Fetuin-A Can Assess the Severity of Alcohol-Related Liver Disease. [PDF]
Salmanoğlu M, Küçük İ, Baş S.
europepmc +1 more source
Objectives Reports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community‐dwelling individuals aged 70 and older.
Amanda J Rickard+15 more
wiley +1 more source
Objective This study aimed to determine if program format (in‐person, virtual, hybrid) results in differences in three‐month outcomes of pain, function, quality of life, self‐efficacy and chair stands in a hip/knee osteoarthritis management program. Methods A secondary analysis of the GLA:DTM Canada database was completed.
Jill Van Damme+7 more
wiley +1 more source
Global Think-tank on Steatotic Liver Disease 2025 meeting. [PDF]
Nedic I+4 more
europepmc +1 more source
Sleep behaviors and metabolic-associated fatty liver disease. [PDF]
Cai Y+5 more
europepmc +1 more source
Artificial intelligence in imaging for liver disease diagnosis. [PDF]
Yin C+5 more
europepmc +1 more source
Metabolic Liver Disease and Cancer Transition: Central Role of the FBP1 Regulatory Axis. [PDF]
Liu Z, Xu J, Zheng S.
europepmc +1 more source
Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). [PDF]
Shakeel L, Shaukat A, Akilimali A.
europepmc +1 more source